FDA issued a Warning Letter to Vilvet Pharmaceutical on 2/25/2019 as a result of this inspection.
483 Vilvet Pharmaceutical Jun 2018

483 Vilvet Pharmaceutical Jun 2018

Christina Theodorou FDA$119.00 - Available Now

FDA investigators audited the Vilvet Pharmaceutical - Chester Springs, PA, United States facility and issued inspectional observations (via FDA 483) on 27 Jun 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Jun 2018
  • Location: Chester Springs, United States
  • FEI: 3013511339
Add To Cart